Seven Eight Capital’s BioNTech BNTX Stock Holding History

Seven Eight Capital’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,691	Closed	-$550K	–	496
2022 Q2	$550K	Buy	+3,691	New	+$564K	0.22%	158
2021 Q2	–	Sell	-20,586	Closed	-$1.68M	–	589
2021 Q1	$1.68M	Hold	20,586	–	–	0.39%	82
2020 Q4	$1.68M	Buy	+20,586	New	+$2.02M	0.38%	82

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Seven Eight Capital's BNTX Position: Q3 2022 in Review

Seven Eight Capital sold out of BioNTech (BNTX) in Q3 2022, closing a stake of 3,691 shares — an estimated $550K sold.

Seven Eight Capital first reported a position in BNTX in Q4 2020 and held it in 3 quarters. The position peaked at $1.68M in Q1 2021. 264 funds tracked by Wall St. Rank hold BNTX as of Q3 2022.

Seven Eight Capital reported no remaining BioNTech position as of Q3 2022 after selling out during the quarter.
Seven Eight Capital sold 3,691 BioNTech shares in Q3 2022, an estimated $550K.
Seven Eight Capital first reported a position in BioNTech in Q4 2020 and held it in 3 quarters.
Seven Eight Capital's BioNTech position peaked at $1.68M in Q1 2021.
264 funds tracked by Wall St. Rank held BioNTech as of Q3 2022.

Based on Seven Eight Capital's 13F filing for Q3 2022, filed 10 Nov 2022.